Ionis Pharmaceuticals Inc
XMUN:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
G
|
Globe Life Inc
F:TMJ
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
XHAM:FME
|
DE |
|
L
|
Lloyds Banking Group PLC
F:LLD
|
UK |
|
R
|
Reckitt Benckiser Group PLC
XMUN:3RB
|
UK |
|
E
|
eBay Inc
F:EBA
|
US |
|
Ambev SA
NYSE:ABEV
|
BR |
|
Bankinter SA
F:BAK
|
ES |
|
John Wiley & Sons Inc
NYSE:WLY
|
US |
|
A
|
American International Group Inc
XMUN:AINN
|
US |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ISI is 78.49 EUR with a low forecast of 52.6 EUR and a high forecast of 104.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
78.49
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 78.49 EUR with a low forecast of 52.6 EUR and a high forecast of 104.8 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.
What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
